Search
Products
Community
Markets
News
Brokers
More
EN
Get started
Markets
/
Israel
/
ETF market
/
TCH.F80
/
Analysis
TC.NASDAQBIO
TCH.F80
Tel Aviv Stock Exchange
TCH.F80
Tel Aviv Stock Exchange
TCH.F80
Tel Aviv Stock Exchange
TCH.F80
Tel Aviv Stock Exchange
Market closed
Market closed
No trades
See on Supercharts
Overview
Analysis
Discussions
Technicals
Seasonals
Key stats
Assets under management (AUM)
41.34 M
ILS
Fund flows (1Y)
−25.38 M
ILS
Dividend yield (indicated)
—
Discount/Premium to NAV
−3.2%
About TC.NASDAQBIO
Issuer
Meitav Investment House Ltd.
Brand
Tachlit
Expense ratio
1.23%
Home page
market.tase.co.il
Inception date
Nov 13, 2018
Index tracked
NASDAQ Biotechnology Index
Management style
Passive
ISIN
IL0011445264
The fund will be managed in a way that is expected to lead to the realization of its mission, achieving results derived from the rate of change in the tracking asset (see details of the tracking asset
Show more
Classification
Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Biotechnology
Weighting scheme
Market cap
Selection criteria
Exchange listed
Returns
1 month
3 months
Year to date
1 year
3 years
5 years
Price performance
—
—
—
—
—
—
NAV total return
—
—
—
—
—
—
What's in the fund
As of September 30, 2024
Exposure type
Bonds, Cash & Other
Government
Cash
Bonds, Cash & Other
100.00%
Government
61.48%
Cash
39.96%
Miscellaneous
−1.44%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows